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Pulmonary rehabilitation (PR) is part of the recommended management
plan of pulmonary hypertension (PHTN) and is important to better quality of life and exercise tolerance. This study aimed at determining effectiveness of PR on exercise capacity. Retrospective chart analysis was
conducted on patients referred to our PHTN clinic for PR. Patients who
had PHTN diagnosed on right heart catheterization (defined by mean
pulmonary artery pressure> 25 mmHg) and completed a standardized
12-week PR program were considered for the study. Patients’ baseline
exercise tolerance was recorded as speed attainable on a treadmill
and duration of exercise in minutes. Demographics, age, sex, and oxygen use were obtained from chart review. Eighteen PHTN patients (5
male, 13 female; mean age 67.7± 11.6 years) were considered for the
study (six World Health Organization [WHO] group 1 pulmonary arterial
hypertension [33.33%], eight WHO group III PHTH [44.44%], two WHO

group IV and two WHO V PHTN [11.11%]). Treadmill speed improved
following rehabilitation (1.3 mph [interquartile range {IQR}, 1.0–1.8 mph]
to 2.2 mph [IQR, 1.3–2.8 mph]; P < 0.0001, Wilcoxon signed rank test).
Median exercise time improved (27 min (IQR, 22–30 min) to 30 min (IQR,
24–30 min); not significant. Improvement was defined only as an increase in speed or duration, or both. Sixteem of 18 participants improved (88.9% [95% exact binomial confidence interval, 65.3%–98.6%).
Patients with PHTN benefit from a structured PR program to improve
their exercise capacity and should be enrolled in PR programs as part
of their management.
Keywords: Pulmonary hypertension, Pulmonary rehabilitation, Pulmonary
arterial hypertension, Treadmill speed, Exercise tolerance

INTRODUCTION

including dyspnea, fatigue and exercise intolerance. Pulmonary
rehabilitation (PR) in patients with PHTN patients is in fact important in the management as it improves outcomes (Sahni et al.,
2015). This study is aimed at determining the effectiveness of
structured PR program on exercise capacity in a population of
PHTN patients.

Pulmonary hypertension (PHTN) is a rare and devastating disease characterized by progressive increases in pulmonary arterial
pressure and pulmonary vascular resistance which eventually leads
to right ventricular failure and death (Badesch et al., 2009; Farber
and Loscalzo, 2004). It may due to various etiologies such as left
heart disease, parenchymal lung disease, chronic thromboembolic
disease, hematologic disorders or it may be idiopathic in nature
though the clinical picture of these patients is similar (Simonneau
et al., 2013). Patients with and advanced lung disease such as
PHTN face symptomatology consistent with oxygen deprivation,

MATERIALS AND METHODS
Study population and design
We conducted a retrospective review of data collected on 18 patients with diagnosis of PHTN who participated in the Northwell
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Table 1. Patient demographics (n= 18)
Demographic
Age (yr)
Sex
Male
Female
WHO groups
I
II
III
IV
V
WHO functional class
I
II
III
IV

Value
67.7± 11.6
5 (27.8)
13 (72.2)
6 (33.3)
0 (0)
8 (44.4)
2 (11.1)
2 (11.1)
1 (5.6)
7 (38.9)
9 (50.0)
1 (5.6)

Values are presented as mean± standard deviation or number (%).
WHO, World Health Organization.

Health PR program. For the purposes of the study PHTN was
defined in accordance to the most updated guidelines of the
American College of Chest Physicians and the European Respiratory Society (Galie et al., 2015). PHTN was defined hemodynamically as a mean resting pulmonary artery pressure greater than or
equal 25 mmHg and pulmonary arterial hypertension (PAH) was
a pulmonary artery wedge pressure less than or equal to 15
mmHg on right heart catheterization (Galie et al., 2015). As the
World Health Organization (WHO) has proposed a classification
system for PHTN based on common clinical features and etiology
which has been outlined in Table 1 (Simonneau et al., 2013). Our
patients were categorized into WHO groups of PHTN based on
underlying etiology of PHTN and completed a standardized 12week PR program to be considered for the study.
Pulmonary rehabilitation
All patients considered for the study completed our PR program. The PR program at our center has been certified by the
American Association of Cardiovascular and Pulmonary Rehabilitation and is designed towards adult patients with chronic lung
disease or patients preparing/recovering from lung surgery. The
program consists of an exercise and education component with
three sessions weekly over a period of 12-week period. Following
the completion of the 12-week program, maintenance sessions are
also available for patients to participate.
The rehab facility at our site is equipped with exercise equip-
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ment such as treadmill, upper/lower body recumbent stepper (NuStep LLC, Ann Arbor, MI, USA), arm ergometers and free weights.
In addition, safety equipments available include: electrocardiogram
monitoring, pulse oximetry, blood pressure monitoring and supplemental oxygen. The education component consists of biweekly
educational lecture series that comprise of breathing techniques
along with stress and relaxation exercises. As part of our PR program all patients are asked to fill out quality of life, fatigue and
sleep questionnaires before and after completion of the program.
At the time of the enrollment in PR, all patients were clinically
stable, and all were receiving optimal medical therapy. Patients’
baseline exercise tolerance was recorded as speed attainable on a
treadmill in miles per hour (mph) and duration of exercise in minutes (min). Demographics, age, sex, New York Heart Association
functional class and oxygen use were obtained from chart review.
Data were analyzed using SAS ver. 9.3 (SAS Institute Inc., Cary,
NC, USA). The change in each component of the treadmill exercise
(speed, grade, duration), was examined using the Wilcoxon signed
rank test. Improvement was defined as an increase in speed or duration (or both), with no decrease in either component). The percent
of subjects who improved based on this definition was then calculated, along with the associated exact binomial 95% confidence interval. Northwell Health System Institutional Review Board approval was obtained for this study (approval number: 14-574).

RESULTS
Eighteen patients with PHTN met the criteria for the study.
There were a total of 5 male and 13 female patients with a mean
age 67.7 ± 11.6 years. Of these patients there were six (33.33%
who were considered WHO group 1 PAH), eight WHO group
III PHTN (44.44%), two WHO group IV, and two WHO V
PHTN (11.11%). Demographics have been outlined in Table 1.
Of these patients, 14 (82.4%) were on supplemental oxygen. It
was found that as a whole across all WHO groups of PHTN,
treadmill speed improved following rehab (P<0.0001, Wilcoxon
signed rank test). Median treadmill speed prior to rehab was 1.3
mph (interquartile range [IQR], 1.0–1.8 mph) and 2.2 mph (IQR,
1.3–2.8 mph) following rehab Fig. 1.
Prior to rehab, median exercise time was 27 min (IQR, 22–30
min), after rehab, median exercise time was 30 min (IQR, 24–30
min). The total exercise time also improved though not found to
be statistically significant. Sixteen of the 18 participants improved
(88.9%; 95% exact binomial confidence interval, 65.3%–98.6%).
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Fig. 1. Pre- and postpulmonary rehabilitation treadmill speed.

DISCUSSION
PHTN treatment is centered on improved cardiopulmonary
hemodynamics resulting in increased exercise tolerance as generally measured by the 6-min walk test. This emerging data has been
seen specifically in the WHO group I PAH (Babu et al., 2016;
Chan et al., 2013). Our study shows exercise tolerance improvements in terms of speed in mph and increased duration of exercise
across multiple etiologies of PHTN after a course of structured
PR. The results of this study also demonstrate that despite diagnostic etiology of PHTN and disease severity structured PR increases exercise tolerance.
The American Thoracic Society and the European Respiratory
Society have defined pulmonary rehabilitation as an “evidence
based, multidisciplinary and comprehensive intervention for patient with chronic respiratory diseases who are symptomatic and
often have decreased daily life activities” (Nici et al., 2006). The
principal purpose of PR programs is to improve function, disease
related symptoms, optimize functional capacity and an overall
improvement in quality of life.
The use PR as an adjuvant to pharmacotherapy is well established (Nici et al., 2006). PR has become a staple of therapy in advanced lung disease including chronic obstructive pulmonary disease (Casaburi et al., 2005), idiopathic pulmonary fibrosis (Raghu
et al., 2011) and PHTN (Mereles et al., 2006) amongst others.
Early thought process of exercise in PHTN was that it may be
harmful, expedite the disease process and may even cause sudden
death. However, evidenced based medicine has proven the opposite to be true (Sahni et al., 2015). The underlying mechanism of
PR resulting in an increased exercise tolerance remains conjectur216
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al. Disease mechanism in PHTN heavily involves endothelin-1
(ET-1), the human body’s most potent vasoconstrictor. Studies
have shown that chronic exercise causes an increase in the production of nitric oxide, a potent vasodilator and a decrease in the production of ET-1 which in turn may net a vasodilatory effect thereby decreasing pulmonary vascular resistances, increasing cardiac
output and increasing exercise tolerance (Maeda et al., 2001). It is
also important to note that the overall increase of speed in our pulmonary rehab patients points to an increase in exercise tolerance
and endurance. Patients who were unable to increase their overall
speed showed an increase in the duration of time there were able
to exercise also pointing to an increased in endurance. A study by
Otsuki et al. (2006) showed that ET-1 concentrations were lower
in individuals who participated in strength or endurance training
as compared to sedentary controls. As the knowledge and beneficial evidence of PR steadily increases the use in PHTN patients
should continue to become part of standard of care.
In conclusion our study was able to show that patients with all
types of PHTN and varying WHO functional class show improvement as measured by speed and time from a structured PR
program. All PHTN patients should be enrolled in PR programs
as part of their management in adjuvant to their pharmacotherapy
and regardless of their WHO functional class.
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